GlassScriptPhysician profile
Jose N Prudencio
NPI 1376590588
$2,119.79
in general payments reported to CMS, 2019-2025
26 companies · $82.79 in 2025
The $82.79 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $361 · 2021: $783 · 2022: $116 · 2023: $164 · 2024: $179 · 2025: $82.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $648.19 | 2019-2021 | |
| Abbvie INC. | $415.48 | 2019-2024 | |
| Neotract INC. | $128.11 | 2019 | |
| Medtronic, INC. | $112.80 | 2021 | |
| Coloplast Corp | $88.75 | 2021-2025 | Speedicath |
| Teleflex LLC | $86.86 | 2021 | |
| Pfizer INC. | $83.32 | 2019-2023 | |
| Allergan, INC. | $76.28 | 2019-2021 | |
| Boston Scientific Corporation | $74.30 | 2019 | |
| Merck Sharp & Dohme LLC | $51.45 | 2024-2025 | Keytruda |
| Dendreon Pharmaceuticals LLC | $41.42 | 2019 | |
| Urovant Sciences INC | $38.17 | 2021 | |
| Blue Earth Diagnostics | $29.60 | 2021 | |
| Janssen Biotech, INC. | $28.88 | 2019 | |
| Palette Life Sciences, INC. | $25.80 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $24.38 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $23.90 | 2021 | |
| Clarus Therapeutics INC. | $21.75 | 2021 | |
| Photocure INC | $18.62 | 2019 | |
| Ambu INC. | $17.35 | 2022 | |
| Lilly USA, LLC | $15.31 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.29 | 2024 | Farxiga |
| Laborie Medical Technologies Corp. | $14.70 | 2025 | |
| Ferring Pharmaceuticals INC. | $13.41 | 2019 | |
| Endo Pharmaceuticals INC. | $13.28 | 2021 | |
| Clovis Oncology, INC. | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Prudencio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.